Market Overview

Morning Market Gainers

Share:

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares jumped 43.53% to $3.66 after the company reported a research collaboration with Bristol-Myers Squibb (NYSE: BMY).

Digital Ally Inc. (NASDAQ: DGLY) shares gained 25.75% to $13.88 after the company reported that it has been awarded a 5 year GSA contract.

Biocept, Inc. (NASDAQ: BIOC) shares climbed 22.37% to $1.77 after the company reported favorable findings from OncoCEE-BR Study.

Celldex Therapeutics, Inc. (NASDAQ: CLDX) jumped 19.28% to $25.30 after the company announced a breakthrough designation from the FDA for its Rintega therapy.

Intellicheck Mobilisa, Inc. (NYSE: IDN) rose 14.22% to $1.6790 after the company reported that it has signed a contract with Helzberg Diamonds to implement ID Check at all U.S. retail locations.

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) surged 12.73% to $195.31 after the company agreed to acquire Salix Pharmaceuticals (NASDAQ: SLXP) for $10 billion.

Polypore International Inc. (NYSE: PPO) gained 12.26% to $59.44. Asahi Kasei Corporation agreed to acquire Polypore for $60.50 per share in cash. Polypore also announced the sale of its media business to 3M Company (NYSE: MMM) for $1 billion.

Tower Semiconductor Ltd. (NASDAQ: TSEM) shares surged 10.08% to $15.07 after the company reported stronger-than-expected earnings for the fourth quarter.

Ballard Power Systems Inc.(NASDAQ: BLDP) shares climbed 9.96% to $2.65 after the company reported the signing of two new technology solutions contracts.

Home Loan Servicing Solutions, Ltd. (NASDAQ: HLSS) shares jumped 8.77% to $18.23 after New Residential Investment Corp. (NYSE: NRZ) announced its plans to acquire HLSS for $18.25 per share in cash

ADMA Biologics, Inc. (NASDAQ: ADMA) shares rose 4.96% to $11.00 after announced positive data from phase III RI-002 trial.

 

Related Articles (RIGL + BMY)

View Comments and Join the Discussion!

Posted-In: Market GainersNews Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com